Association of post-transplant outcomes with induction intensity in patients with acute myeloid leukemia.

Melanie Rebechi,Kieran D. Sahasrabudhe,Ying Huang,Patrick Elder,Bradley W. Blaser,Jonathan E. Brammer,Hannah Kyung Choe,Yvonne A. Efebera,Ann-Kathrin Eisfeld,Samantha Jaglowski,Karilyn Larkin,Meixiao Long,Alice S. Mims,Sam Penza,Ayman Saad,Sumithira Vasu,Sarah A Wall

Association of post-transplant outcomes with induction intensity in patients with acute myeloid leukemia.

2021

Melanie Rebechi
Kieran D. Sahasrabudhe
Ying Huang
Patrick Elder
Bradley W. Blaser
Jonathan E. Brammer
Hannah Kyung Choe
Yvonne A. Efebera
Ann-Kathrin Eisfeld
Samantha Jaglowski
Karilyn Larkin
Meixiao Long
Alice S. Mims
Sam Penza
Ayman Saad
Sumithira Vasu
Sarah A Wall

e19026Background: The USFDA has recently approved several oral targeted therapies for the treatment of acute myeloid leukemia (AML). The relative survival impact of these agents vs standard inducti...

Keywords:

in patient
Oncology
Medicine
post transplant
Intensity (physics)
Relative survival
Myeloid leukemia
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations